XML 48 R33.htm IDEA: XBRL DOCUMENT v3.20.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

For 2020, 2019, and 2018, the fair value of each option grant was estimated using the Black-Scholes option-pricing model, using the following assumptions:

Years Ended December 31, 

    

2020

    

2019

    

2018

Expected option life (years)

5.50 - 6.25

5.50 - 6.25

5.48 - 6.25

Risk-free interest rate

 

0.31% - 1.63%

  

1.91% - 2.58%

 

2.64% - 2.93%

Expected stock price volatility

 

49.2% - 51.2%

  

63.1% - 66.7%

 

55.1% - 60.6%

Dividend yield

 

 

Summary of Stock option and restricted stock activity

A summary of stock option activity under the 2008 Plan and Inducement Grant during the years ended December 31, 2020, 2019, and 2018 is presented below:

    

    

    

Weighted

    

Weighted

    

Average

Average

Weighted

Grant-

Remaining

(in thousands, except per share and

Option

Average

date

Term

Aggregate

remaining term data)

Shares

Exercise Price

Fair Value

(years)

Intrinsic Value

Outstanding December 31, 2017

 

767

$

42.93

 

7.8

$

16,785

Granted

 

156

 

57.60

$

31.76

Exercised

 

(142)

 

19.47

 

5,863

Forfeited

 

(18)

 

60.17

Expired

 

(4)

 

74.53

Outstanding December 31, 2018

 

759

$

49.74

 

7.6

$

2,221

Granted

 

160

 

65.97

$

40.14

Exercised

 

(130)

 

41.99

 

3,335

Forfeited

 

(31)

 

56.66

Expired

 

(1)

 

54.36

Outstanding at December 31, 2019

 

757

$

54.21

 

7.2

$

6,761

Granted

 

231

 

30.29

$

14.39

Exercised

 

(8)

 

36.81

 

216

Forfeited

 

(44)

 

54.54

Expired

 

 

Outstanding at December 31, 2020

 

936

$

48.44

 

7.1

$

372

Exercisable at December 31, 2020

 

571

$

53.06

 

5.9

$

347

Non-vested Restricted Stock Shares Activity

A summary of RSA activity under the Plan during the years ended December 31, 2020, 2019, and 2018 is presented below:

    

    

Weighted

    

Average Grant

Weighted Average

(in thousands, except per share and

Date Fair

Remaining Term

remaining term data)

Shares

Value

(years)

Unvested at December 31, 2017

 

85

$

48.34

 

2.6

Granted

 

65

 

58.11

 

  

Vested

 

(33)

 

47.34

 

  

Forfeited

 

 

 

  

Unvested at December 31, 2018

 

117

$

54.04

 

2.1

Granted

 

122

 

66.39

 

  

Vested

 

(42)

 

54.77

 

  

Forfeited

 

(5)

 

62.63

 

  

Unvested at December 31, 2019

 

192

$

61.46

 

2.6

Granted

 

305

 

44.42

 

  

Vested

 

(127)

 

58.88

 

  

Forfeited

 

(18)

 

51.53

 

  

Unvested at December 31, 2020

 

352

$

48.14

 

2.7

Employee Stock Purchase Plan 2016 [Member]  
Summary of allocated expense

(in thousands)

Years Ended December 31, 

    

2020

    

2019

    

2018

Cost of sales

$

21

$

18

$

11

Research and development

 

36

 

29

 

16

Selling, general, and administrative

 

123

 

100

 

75

$

180

$

147

$

102

Stock Incentive Plan 2008 [Member]  
Summary of allocated expense

Years Ended December 31, 

(in thousands)

    

2020

    

2019

    

2018

Cost of sales

$

115

$

101

$

87

Research and development

 

561

 

756

 

771

Selling, general, and administrative

 

12,080

 

8,213

 

5,822

$

12,756

$

9,070

$

6,680